Industry comparison

Manufacture of pharmaceuticals by size bands.

Compare the eligible Manufacture of pharmaceuticals cohort across size bands. Each row keeps company scale alongside health, profitability, growth and risk context.

SIC 2150-company minimum cohort Calculated 2 Jul 2026
Compare regionsIndustry profile
Comparable size bands1Eligible public cohorts
Company base1,963Across displayed size bands
Largest cohort1,963Micro / turnover unreported
Largest cohort health66Largest cohort’s average score
Eligible rows13 excluded below cohort
Invalid metric rows0Omitted instead of inferred

Cohort comparison

Manufacture of pharmaceuticals by size bands

Ranked by company count. Profitability is a derived 0–100 score; lower insolvency-risk score is safer.

1 rows
#company sizeCompaniesHealth scoreProfitability scoreGross marginGrowthRisk
1 Micro / turnover unreportedMicro · find companies 1,963 66 41 66.1% 8.3% 27
Benchmark context Companies House aggregate snapshot Minimum cohort 50 Calculated 2 Jul 2026 Aggregate benchmark snapshot from Companies House-derived data. Rows below the minimum public cohort of 50 companies are excluded. At least two distinct eligible size cohorts are required for a public comparison. The current source refresh groups companies with unreported turnover into Micro. The Micro / turnover unreported row is not a pure turnover-size cohort.